KOSDAQChemicals036640

HRS

₩4,690▼ 1.16%2026-11-18 close
Market Cap
₩76.7B
Turnover
₩54,369,450
Volume
10K
Shares out.
16.4M
PER
5.5×
PBR
0.6×
EPS
₩874
Dividend Yield
6.19%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩300 per share · Prices as of the 2026-11-18 close

01

Report overview

Margins Held Up, but Third-Quarter Profit Slowed

HRS's annual revenue has stayed in the KRW 78–86 billion range since 2022, while its operating margin rose from 13.3% to 18.6%. In the third quarter of 2026, revenue grew year on year, but operating profit and profit attributable to controlling shareholders both declined.

  1. 1

    Revenue fell from KRW 86.1 billion in 2022 to KRW 78.9 billion in 2025, while the operating margin climbed from 13.3% in 2022 to 18.6% in 2024 before easing to 17.0% in 2025.

  2. 2

    Second-quarter 2026 revenue of KRW 24.7 billion and operating profit of KRW 4.38 billion were the highest of the last five quarters, but the third quarter fell back to KRW 21.1 billion and KRW 3.2 billion.

  3. 3

    A new plant in Pyeongtaek is in preparation. KRW 29.5 billion was spent on land and buildings, with operations planned for around 2028.

  4. 4

    As of the end of 2025, the debt ratio was 9.9%, and total equity of KRW 129.6 billion was entirely attributable to controlling shareholders, indicating a light debt burden.

  5. 5

    At the March 2026 annual general meeting, the 45th-term financial statements were approved and a cash dividend was resolved. Whether dividend capacity tracks earnings will be the next point to watch.

02

Business structure

HRS is a specialty silicone materials company founded in 1981 that compounds and processes silicone rubber into compounds and finished products. It purchases GUM as its raw material and processes it in-house, with high consistency silicone rubber (HCR) and liquid silicone rubber (LSR) as the core product lines.

Other products include room-temperature vulcanizing (RTV) silicone, silicone sheets, silicone fire-stop products, dental impression materials, pressure-sensitive adhesives (PSA), and cosmetic and household materials. Its customers span electronics, IT, home appliances, automotive and medical applications.

The company is competitive in a high-mix, low-volume production model, where it can respond to customer-specific requirements rather than only standard products.

Its history includes localizing silicone products that had previously been imported, which has positioned it as a leader in domestic specialty silicone manufacturing. It has entered the North American and European markets and is diversifying into nuclear power, electric vehicles and high-function cosmetic ingredients.

Its production base is moving toward a new Pyeongtaek plant, where KRW 29.5 billion was spent on land and buildings, with design work in 2026 and operations planned for around 2028.

Being classified as a small and medium-sized enterprise, it differs in structure from large petrochemical groups and targets niches within specialty silicone applications.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩20.8B₩3.9B19.0%
2025Q4₩19B₩2.4B12.5%
2026Q1₩20.9B₩3.1B14.7%
2026Q2₩24.7B₩4.4B17.7%
2026Q3₩21.1B₩3.2B15.2%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩86.1B₩11.4B₩10B13.3%9.4%9.8%
2023₩78.2B₩12.5B₩12.1B16.0%10.6%9.6%
2024₩80.2B₩14.9B₩15.1B18.6%12.3%10.7%
2025₩78.9B₩13.4B₩13.5B17.0%10.4%9.9%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-12

04

Earnings analysis

Annual revenue fell from KRW 86.1 billion in 2022 to KRW 78.2 billion in 2023, down 9.2% year on year, then rose to KRW 80.2 billion in 2024, up 2.6%, before slipping to KRW 78.9 billion in 2025, down 1.7%. Among 2022–2025, 2022 was the largest revenue year and 2023 the smallest.

Operating profit was KRW 11.4 billion in 2022, KRW 12.5 billion in 2023 (up 9.5%), KRW 14.9 billion in 2024 (up 19.3%) and KRW 13.4 billion in 2025 (down 10.2%), with 2024 the largest year. Because revenue stayed in a narrow band, the swings in operating profit mainly reflected margin changes.

The operating margin was 13.3% in 2022, 16.0% in 2023, 18.6% in 2024 and 17.0% in 2025, peaking in 2024 and easing slightly afterward.

Profit attributable to controlling shareholders was KRW 10 billion in 2022, KRW 12.1 billion in 2023 (up 20.7%), KRW 15.1 billion in 2024 (up 24.8%) and KRW 13.5 billion in 2025 (down 10.5%).

Net income including non-controlling interests was reported at KRW 10 billion, KRW 12.1 billion, KRW 15.1 billion and KRW 13.5 billion for the same years. Operating cash flow was KRW 14.9 billion in 2022, KRW 20.4 billion in 2023, KRW 14.2 billion in 2024 and KRW 15.7 billion in 2025.

On a quarterly basis, the third quarter of 2025 posted revenue of KRW 20.8 billion, operating profit of KRW 3.94 billion and profit attributable to controlling shareholders of KRW 3.72 billion.

The fourth quarter of 2025 fell to revenue of KRW 19 billion, down 8.4% from the prior quarter, and operating profit of KRW 2.39 billion, down 39.4%. The first quarter of 2026 recorded revenue of KRW 20.9 billion and operating profit of KRW 3.07 billion.

The second quarter of 2026 rose to revenue of KRW 24.7 billion, up 18.5% from the prior quarter, operating profit of KRW 4.38 billion, up 42.8%, and profit attributable to controlling shareholders of KRW 6.92 billion, up 130.5%.

The third quarter of 2026 came in at revenue of KRW 21.1 billion, down 14.6% from the prior quarter but up 1.6% year on year, operating profit of KRW 3.2 billion, down 26.9% quarter on quarter and down 18.8% year on year, and profit attributable to controlling shareholders of KRW 1.54 billion, down 77.8% quarter on quarter and down 58.7% year on year.

Because second-quarter profit attributable to controlling shareholders exceeded operating profit, non-operating items or taxes may have contributed. Profit attributable to controlling shareholders over the latest four quarters totaled KRW 14.2 billion.

05

Industry analysis

Silicone materials are used in areas such as thermal management and thermal runaway prevention inside electric vehicle battery packs, so end demand spans electric vehicles, electronics and medical applications.

However, HRS's revenue fell 1.7% in 2025, and third-quarter 2026 revenue rose only 1.6% year on year, so the data does not show a clear acceleration in end demand.

The company's earnings commentary notes that the prolonged war, high interest rates and high inflation have disrupted supply chains and raised raw material price volatility, limiting revenue and profitability. Because raw material prices drive margins, cost swings flow directly into quarterly profit.

In the 2025 year-end industry comparison on wisereport, HRS's dividend yield was above the average of the KOSDAQ chemicals sector, while its PER was below the sector average.

Peers in the same chemicals industry such as KCC, Kumho Petro Chemical and Lotte Chemical differ in scale and product mix, which limits direct comparison. HRS concentrates on silicone product lines, so its results tend to move with specific customer groups and demand cycles.

Its entry into North America and Europe adds regional diversification. Whether the business is in a recovery or slowdown phase is best read from the quarterly revenue path, which peaked at KRW 24.7 billion in the second quarter of 2026 and fell to KRW 21.1 billion in the third quarter.

06

Outlook

The most concrete medium-term milestone for HRS is its new Pyeongtaek plant. KRW 29.5 billion was spent on land and buildings, with design work in 2026 and operations planned for around 2028.

LS Securities has analyzed that the new plant could expand production capacity and strengthen production linkages, potentially improving profitability. This is the brokerage's interpretation rather than company guidance.

Until the plant starts, results will rest on existing facilities and demand, so the near-term question is whether operating profit keeps falling even as revenue grows.

Third-quarter 2026 operating profit was KRW 3.2 billion, down 18.8% year on year, and profit attributable to controlling shareholders was KRW 1.54 billion, down 58.7%.

Whether the KRW 6.92 billion second-quarter 2026 profit attributable to controlling shareholders was one-off will be clearer from upcoming quarterly results. On dividends, a cash dividend was resolved at the March 2026 annual general meeting alongside the 45th-term financial statements. The next dividend decision is expected at the annual general meeting in 2027, tied to the 2026 annual report.

07

Valuation

PER
5.5×
PBR
0.6×
ROE
10.7%
EPS
₩874
BPS
₩8,444
Dividend per share
₩300

Valuation can be read along two lines, net assets and earnings. The price-to-book ratio sits below 1x, which means the shares trade at a discount to net asset value.

Total equity of KRW 129.6 billion is entirely attributable to controlling shareholders, with total liabilities of KRW 12.9 billion and a debt ratio of 9.9%, so the balance sheet structure is simple.

On earnings, profit attributable to controlling shareholders fell 10.5% in 2025, and third-quarter 2026 profit fell 58.7% year on year, so the direction of earnings power is mixed. Over the latest four quarters, profit attributable to controlling shareholders totaled KRW 14.2 billion.

In the 2025 year-end industry comparison on wisereport, the dividend yield was above the KOSDAQ chemicals sector average, while the multiple was below it.

Over several years, the operating margin recovered from 13.3% in 2022 to 18.6% in 2024 before easing to 17.0% in 2025, so the trend is a recovery followed by a moderate pullback rather than a sustained decline. A cash dividend was resolved at the March 2026 annual general meeting. Taken together, the shares trade at a discount to book value while earnings remain volatile.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-12

08

Bull factors

Sustained high operating margin

The operating margin rose from 13.3% in 2022 to 18.6% in 2024 and held at 17.0% in 2025. Revenue stayed in the KRW 78–86 billion range over the same period, so the margin gain points to a stronger earnings structure rather than revenue expansion. LS Securities cited a five-year average operating margin of 16.9%.

Near debt-free balance sheet

The debt ratio at the end of 2025 was 9.9%, with total liabilities of KRW 12.9 billion. Total equity of KRW 129.6 billion is entirely attributable to controlling shareholders, which gives the company relatively wide financial room. This structure means limited borrowing pressure even when raw material prices are volatile.

New plant and overseas expansion

The Pyeongtaek plant involved KRW 29.5 billion in land and building purchases, with design work in 2026 and operations planned for around 2028. Entry into North America and Europe is broadening the portfolio toward nuclear power, electric vehicles and high-function cosmetic ingredients.

09

Bear factors

Third-quarter profit decline

Third-quarter 2026 revenue reached KRW 21.1 billion, up 1.6% year on year, but operating profit fell 18.8% to KRW 3.2 billion. Profit attributable to controlling shareholders fell 58.7% to KRW 1.54 billion, so revenue growth did not carry through to earnings. Given the KRW 6.92 billion spike in second-quarter profit, quarterly earnings volatility is high.

Stagnant and shrinking revenue

Revenue declined from KRW 86.1 billion in 2022 to KRW 78.2 billion in 2023, recovered to KRW 80.2 billion in 2024, and then fell 1.7% to KRW 78.9 billion in 2025. No year since 2022 has shown a clear revenue expansion. Profit growth has depended on margin improvement, so the drivers of top-line growth remain limited.

Cost pressure and investment burden

The prolonged war, high interest rates and high inflation have caused supply chain disruptions and raw material price volatility. Because HRS purchases and processes raw materials, cost increases pass through quickly to margins. The KRW 29.5 billion Pyeongtaek investment could also weigh on results before the plant begins operating.

10

Risk factors

Macro and raw materials

The prolonged war, high interest rates and high inflation are affecting supply chains and raw material prices. Higher GUM prices could compress processing margins, and rising rates could reduce customers' capital spending. These are external variables that the company cannot easily control.

Expansion execution

The Pyeongtaek plant targets operations around 2028 after design work in 2026. Delays in start-up or weaker-than-expected demand would postpone the return on investment. Until the plant starts, results will depend on existing facilities.

Earnings volatility

Second-quarter 2026 profit attributable to controlling shareholders of KRW 6.92 billion exceeded operating profit of KRW 4.38 billion, then fell to KRW 1.54 billion in the third quarter. If non-operating or tax items drive much of the swing, quarterly results are harder to read as underlying earnings power. Dividend capacity could also shift with earnings volatility.

11

What to watch next

  1. Early February 2027

    Fourth-quarter 2026 results. The key points are whether the operating margin holds near the second- and third-quarter 2026 levels and whether quarterly revenue stays in the KRW 20 billion range.

  2. Late March 2027

    Submission of the 2026 annual report and the annual general meeting. Annual operating profit, profit attributable to controlling shareholders, changes in total equity and the dividend resolution can be checked.

  3. Mid-May 2027

    The first-quarter 2027 quarterly report. The key point is whether the operating profit decline seen in the third quarter of 2026 continues.

  4. During 2027

    Progress on design, permits and construction at the Pyeongtaek plant, and whether the target of operations around 2028 and the investment scale hold.

12

Overall view

Since 2022, HRS's revenue has stayed in the KRW 78–86 billion range while its operating margin rose from 13.3% to 18.6%, holding at 17.0% in 2025. The balance sheet is light, with a debt ratio of 9.9%, and total equity of KRW 129.6 billion is entirely attributable to controlling shareholders.

On the other hand, third-quarter 2026 revenue rose 1.6% year on year, yet operating profit fell 18.8% and profit attributable to controlling shareholders fell 58.7%. Whether the KRW 6.92 billion second-quarter 2026 profit was one-off remains open.

The Pyeongtaek plant, with KRW 29.5 billion invested and operations planned for around 2028, makes the timing of expansion benefits a key variable. A cash dividend was resolved at the March 2026 annual general meeting, and the next decision falls at the 2027 annual general meeting.

The shares trade at a discount to book value, but earnings volatility means earnings trends and plant timing need to be read together. The next checkpoints are the fourth-quarter 2026 results, the 2026 annual report, the first-quarter 2027 report and progress at the new plant.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. file.alphasquare.co.kr
  2. comp.wisereport.co.kr
  3. comp.fnguide.com
  4. ssl.pstatic.net
  5. news.nate.com
  6. thinkpool.com
  7. uk.investing.com
  8. calculator.io.kr
  9. edaily.co.kr
  10. webdisclosure.com
  11. financialcontent.com
  12. webdisclosure.com
  13. webdisclosure.com
  14. investing.com
  15. m.jobkorea.co.kr
  16. boursorama.com
  17. saramin.co.kr
  18. actusnews.com

Report written 2026-11-13 · Data as of 2026-11-12

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis